Notícias Mainz BioMed NV - MYNZ | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Mainz BioMed NV (MYNZ)
Mainz BioMed NV (MYNZ) Notícias

Mainz BioMed NV (MYNZ)

4,45

-0,15

( -3,26% )

Atualizado: 14:19:38

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Mainz Biomed Reports First Half 2022 Financial Results

Mainz Biomed to Present at the H.C. Wainwright Annual Global Investment Conference

Mainz Biomed Appoints Dr. D. Kim Turgeon of University of Michigan Health to its Medical Advisory Board

Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates

Mainz Biomed Appoints Former QIAGEN Executive Dr. Frank Krieg-Schneider as Vice President of Development

Mainz Biomed Appoints Dr. Timothy Wang to Newly Formed Medical Advisory Board

Mainz Biomed Today to Provide Corporate Update for First Half of 2022

Mainz Biomed Provides Corporate Update for First Half of 2022

Mainz Biomed Enrolls First Patient in ColoFuture Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert

Mainz Biomed Appoints Vice President of Clinical Affairs to Lead US Clinical Studies in Support of FDA Submission

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Mainz Biomed Successfully Completes Conformity Assessment to IVDR Achieving New Level of EU Regulatory Compliance

Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert in Europe and the United Arab Emirates (UAE)

7
8
9
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Mainz BioMed NV

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições